Marrone Bio Innovations

Marrone Bio Innovations Financing Cash Flow

Delisted

The Net Financing Cash Flow of Marrone Bio Innovations (MBII) as of Nov 18, 2026 is 15.59 M USD. In the previous year, Net Financing Cash Flow was 27.35 M USD — a change of -43.00% (lower).

Financing Cash Flow

15.59 MUSD

YoY

-43.00%

Last updated:

Net Financing Cash Flow of Marrone Bio Innovations is 2021 15.59 M USD. Net Financing Cash Flow of Marrone Bio Innovations was 2020 27.35 M USD. It decreases by -43.00% lower compared to the previous year.

The Marrone Bio Innovations Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
46.13 M USD
Jan 1, 2015
46.13 M USD
Jan 1, 2016
14.29 M USD
Jan 1, 2017
13.05 M USD
Jan 1, 2018
36.95 M USD
Jan 1, 2019
16.16 M USD
Jan 1, 2020
27.35 M USD
Jan 1, 2021
15.59 M USD
The Marrone Bio Innovations Financing Cash Flow history
YEARFinancing Cash FlowYoY
15.59 MUSD-43.00%
27.35 MUSD+69.18%
16.16 MUSD-56.26%
36.95 MUSD+183.23%
13.05 MUSD-8.68%
14.29 MUSD-69.03%
46.13 MUSD0.00%
46.13 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

Net Financing Cash Flow of Marrone Bio Innovations is 15.59 M USD in 2021.

Net Financing Cash Flow of Marrone Bio Innovations changed from 27.35 M USD to 15.59 M USD, representing a -43.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Marrone Bio Innovations since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Marrone Bio Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations